SFM
ABBV icon

Sphera Funds Management’s AbbVie ABBV Stock Holding History

Sphera Funds Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-225,000
Closed -$24.1M – 171
2020
Q4 		$24.1M Buy
225,000
+100,000
+80% +$9.61M 2.14% 12
2020
Q3 		$10.9M Buy
+125,000
New +$11.8M 1.08% 25

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sphera Funds Management's ABBV Position: Q1 2026 in Review

Sphera Funds Management increased its AbbVie (ABBV) stake by 20% in Q1 2026, buying an estimated $1.11M and bringing the position to 30,256 shares worth $6.58M. The position accounts for 1.05% of the portfolio, ranked #35.

Sphera Funds Management first reported a position in ABBV in Q3 2014 and has held it in 30 quarters since. The position peaked at $72.1M in Q2 2020. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Sphera Funds Management held 30,256 shares of AbbVie worth $6.58M as of Q1 2026.
  • Sphera Funds Management bought 5,000 AbbVie shares in Q1 2026, an estimated $1.11M.
  • AbbVie made up 1.05% of Sphera Funds Management's portfolio in Q1 2026, its #35 holding.
  • Sphera Funds Management first reported a position in AbbVie in Q3 2014 and has held it in 30 quarters since.
  • Sphera Funds Management's AbbVie position peaked at $72.1M in Q2 2020.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.